PHENDIMETRAZINE TARTRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for phendimetrazine tartrate and what is the scope of patent protection?
Phendimetrazine tartrate
is the generic ingredient in nineteen branded drugs marketed by Valeant, Numark, Graham Dm, Virtus, Shire Richwood, Mast Mm, Sandoz, Vitarine, Solvay, Teva, Ferndale Labs, Abc Holding, Camall, Chartwell Rx, Pvt Form, Forest Pharms, Barr, Chartwell, Elite Labs Inc, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Nexgen Pharma Inc, Nostrum Labs Inc, Upsher Smith Labs, Usl Pharma, Watson Labs, and Wyeth Ayerst, and is included in ninety-six NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for phendimetrazine tartrate. Twelve suppliers are listed for this compound.
Summary for PHENDIMETRAZINE TARTRATE
US Patents: | 0 |
Tradenames: | 19 |
Applicants: | 31 |
NDAs: | 96 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 2,768 |
Drug Prices: | Drug price trends for PHENDIMETRAZINE TARTRATE |
What excipients (inactive ingredients) are in PHENDIMETRAZINE TARTRATE? | PHENDIMETRAZINE TARTRATE excipients list |
DailyMed Link: | PHENDIMETRAZINE TARTRATE at DailyMed |
Pharmacology for PHENDIMETRAZINE TARTRATE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vitarine | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 086005-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 085770-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Upsher Smith Labs | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 084399-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Numark | SPRX-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 088024-001 | Dec 22, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 083686-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | CAM-METRAZINE | phendimetrazine tartrate | TABLET;ORAL | 085321-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nexgen Pharma Inc | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 086020-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.